Fusion Pharmaceuticals Inc.
Fusion Pharmaceuticals Inc. (FUSN) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
fusn · stock forecast · 15 analysts (3M) · FMP · updated Apr 25, 2025
Analyst Rating & Consensus
Based on 15 Wall Street analysts in the past 3 months
Hold
15 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$21.00
Consensus
$15.25
-29.2% upside
Low
$6.00
Median: $17 · Last Close: $21.55
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$15.25
-29.2% upside
High Target
$21
-2.6%
Low Target
$6
-72.2%
Current Price
$21.55
as of today
Based on analyst price targets, the FUSN stock price prediction for the next 12 months ranges from $6 to $21. The consensus FUSN price forecast of $15.25 implies -29.2% upside from the current price of $21.55.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $21.55 | ↑ 0.00% |
1-day model range: $21.54–$21.56. Peak: $21.56 (+0.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $18 | -16.5% |
| 2028 | $16 | -24.1% |
| 2029 | $16 | -27.8% |
| 2030 | $15 | -29.8% |
| 2031 | — | -30.9% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · FUSN · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-04-16 | TD Cowen | Downgrade ↓ | Buy→Hold |
| 2024-03-21 | RBC Capital | Maintains | Sector Perform→Sector Perform |
| 2024-03-21 | Wedbush | Maintains | Neutral→Neutral |
| 2024-03-20 | Truist Securities | Downgrade ↓ | Buy→Hold |
| 2024-03-20 | Raymond James | Downgrade ↓ | Strong Buy→Market Perform |
| 2024-03-20 | JonesTrading | Downgrade ↓ | Buy→Hold |
| 2024-03-20 | RBC Capital | Downgrade ↓ | Outperform→Sector Perform |
| 2024-03-20 | B. Riley Securities | Downgrade ↓ | Buy→Neutral |
| 2024-03-19 | Brookline Capital | Downgrade ↓ | Buy→Hold |
| 2024-03-19 | Jefferies | Downgrade ↓ | Buy→Hold |
Wall Street analysts have recently issued updated ratings on Fusion Pharmaceuticals Inc. (FUSN) stock. Of the recent 47 rating actions, 1 were upgrades and 13 were downgrades. 15 analysts currently cover FUSN.
Analyst Recommendation Trends
FUSN analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$4M
↓ 64.2% YoY
Revenue Next Year
$1M
↓ 86.3% YoY
EPS This Year
$-1.44
EPS Next Year
$-1.60
↑ 11.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast FUSN EPS of $-1.44 for the current fiscal year, based on estimates from 7 analysts. The FUSN revenue forecast is $4M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The FUSN stock forecast is supported by two independent data sources: analyst consensus ratings from 15 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus FUSN price target is $15.25 (-29.2% upside), with an analyst consensus of Hold.
The FUSN short-term stock prediction for tomorrow is $21.55 (+0.00%). The FUSN stock price prediction for 2027 estimates an average of $18. The FUSN stock prediction for 2030 projects a range of $15–$15.
Fusion Pharmaceuticals Inc. trades on NASDAQ under the ticker FUSN. The FUSN stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 27% of covering analysts.
Frequently asked questions
FUSN forecast · 8 questionsAccording to 15 Wall Street analysts, the average 12-month FUSN price target is $15.25, with a high forecast of $21.00 and a low of $6.00. The median price target is shown in the chart above when available. This implies -29.2% potential upside from the current price of $21.55.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.